Eric Angevin
0000-0001-6249-7209
3 papers found
Refreshing results…
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein–Expressing Non–Small-Cell Lung Cancer
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours
Missing publications? Search for publications with a matching author name.